There is increasing attention on the complex interactions occurring between schistosome parasites and their hosts. However, little is known about the occurrence, epidemiology, and mechanisms of schistosomiasis-associated infertility. In this article, we argue that an in-depth understanding of the interplay between parasites and the host endocrine system may significantly enhance current knowledge of infertility in infected individuals. We discuss the basic hormonal mechanisms that may lead to the discovery of entirely novel anthelmintic interventions against schistosomiasis. Schistosomiasis and Infertility Infertility is defined as the incapacity to become pregnant after 12 months of regular and unprotected intercourse. This is a major public health problem that affects about one in six couples (15-20%) worldwide and 12-30% of couples in sub-Saharan Africa [1-3]. It is well recognized as a major sequela of genital tract infection; many women in Africa with this ailment (85-90%) suffer from subsequent infertility, and the cause can be attributed to pelvic infections [4]. Numerous diseases, including febrile diseases, sexually transmitted infections (STDs), and various parasitic infections, such as microfilaria and schistosomiasis, can cause infertility [5]. When considering the diagnosis of infertility there are two main features of this disease: primary infertility, considered when the woman never conceived, and secondary infertility when she had had a previous labor [5]. Most articles addressing infertility-associated schistosomiasis describe only primary infertility, and we found only two reports in the literature describing secondary infertility: one from our group [5] and one from another group [6], both reporting a lack of association between secondary infertility and schistosomiasis.